The biosimilar market is expanding rapidly, driven by the growing demand for cost-effective biologic therapies, patent expirations of blockbuster drugs, and increasing approvals worldwide. Biosimilars offer comparable efficacy and safety to reference biologics at lower costs, improving access to treatment for chronic diseases like cancer, diabetes, and autoimmune disorders. Regulatory... https://www.imarcgroup.com/biosimilar-market